D. Cholon - AI Profile | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 12 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

309 The CFTR Antibody Distribution Program: Development and production of antibodies for CFTR detection

T. Jensen,D. Cholon,L. Aleksandrov, A. Aleksandrov,M. Gentzsch

Journal of Cystic Fibrosis (2023): S155-S155

引用0浏览0引用

176 Cystic fibrosis airway inflammation enhances the efficacy of CFTR modulators

C. Ribeiro,J. Minges,N. Quinney,S. Boyles, K. Okuda,D. Cholon,C. Esther,M. Gentzsch

Journal of Cystic Fibrosis (2023): S92-S93

引用0浏览0引用

311 Active Pseudomonas aeruginosa infection of primary airway epithelia enhances CFTR modulator rescue

D. Cholon, M. Higgs,S. Boyles,N. Quinney,S. Meinig,J. Minges, C. Ribeiro,M. Wolfgang,M. Gentzsch

Journal of Cystic Fibrosis（2023）

引用0浏览0引用

156 Primary pharmacology and toxicology of TAVT-135, a novel chloride ion transporter in development for the treatment of cystic fibrosis

A. Maetzel,M. Gentzsch,J. Maleth, I. Misāne, O. Basa-Denes, L. Molnar,S. Boyles,D. Cholon, I. Mandity, R. Ilagan

Journal of Cystic Fibrosis (2023): S83-S83

引用0浏览0引用

201 SCGB3A2-positive distal airway secretory cells are a therapeutic target for CFTR function restoration

A. Cawley, S. Nakano, A. Singh, Z. Wisniewski,H. Dang,L. Morton,R. Gilmore,T. Asakura,N. Quinney,S. Boyles,D. Cholon, S. Kelly,

Journal of Cystic Fibrosis (2023): S105-S105

引用0浏览0引用

325 Corrector elexacaftor mimics potentiator action by increasing numbers of functional CFTR channels via recovery of rescued inactivated F508del

A. Aleksandrov,L. Aleksandrov,D. Cholon,S. Boyles,N. Quinney,M. Gentzsch

Journal of Cystic Fibrosis (2023): S162-S162

引用0浏览0引用

659 Inflammation augments elexacaftor/tezacaftor/ivacaftor-induced cystic fibrosis transmembrane conductance regulator rescue in primary airway epithelia carrying F508del and rare cystic fibrosis transmembrane conductance regulator mutations

M. Gentzsch,D. Cholon,N. Quinney,S. Boyles,J. Minges,C. Ribeiro

Journal of Cystic Fibrosis (2022)

引用0浏览0引用

676 A multicenter approach to optimize and validate a robust cystic fibrosis transmembrane conductance regulator–specific immunolabeling protocol

J. Lu,D. Cholon, K. Du, C. Penton, J. Sheridan,C. Cotton,M. Mense,C. Bear,M. Gentzsch,J. Mahoney

Journal of Cystic Fibrosis（2022）

引用0浏览0引用

449 Pathways balancing basal mucin and cystic fibrosis transmembrane conductance regulator–mediated fluid secretion in the human small airway

K. Okuda,S. Nakano,A. Singh,H. Dang,L. Morton,R. Gilmore,R. Lee,S. Gallant,N. Quinney,D. Cholon,M. Gentzsch,S. Randell,

Journal of Cystic Fibrosis (2022): S257-S258

引用0浏览0引用

647 Potentiator icenticaftor is superior to ivacaftor in rescuing F508del cystic fibrosis transmembrane conductance regulator and does not destabilize corrected mature protein

D. Cholon,L. Aleksandrov,N. Quinney,S. Boyles, A. Aleksandrov,M. Gentzsch

Journal of Cystic Fibrosis (2022): S355-S355

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn